Type 2 diabetes mellitus
MONDO:0005148A type of diabetes mellitus that is characterized by insulin resistance or desensitization and increased blood glucose levels. This is a chronic disease that can develop gradually over the life of a patient and can be linked to both environmental factors and heredity.
Also known as: NIDDM, T2D, T2DM, T2DM - type 2 diabetes mellitus, adult onset diabetes, adult-onset diabetes, diabetes mellitis type 2, diabetes mellitis type II
1953 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Hospital metformin debate: keep or stop? small study offers few answers.
Disease control TerminatedThis study looked at whether people with type 2 diabetes should continue taking their usual metformin medication while hospitalized. The goal was to see if it helped control blood sugar, caused stomach issues, or affected how long patients stayed. Only 22 people took part before …
Phase: PHASE4 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Can a glucose monitor boost diabetes education for newly diagnosed patients?
Disease control TerminatedThis study tested whether using a Freestyle Libre 2 continuous glucose monitor for 28 days, along with standard therapeutic education, helps people recently diagnosed with type 2 diabetes improve their blood sugar control. The trial enrolled 27 adults diagnosed within the past ye…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Diabetes drug adherence study halted after just one participant
Disease control TerminatedThis study aimed to see if following the exact dosing instructions for oral semaglutide helps control blood sugar in people with type 2 diabetes who are already on metformin. Only one person enrolled before the study was stopped early. The main focus was on changes in blood sugar…
Sponsor: Aalborg University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Experimental diabetes drug AP026 tested in early trial – but study halted
Disease control TerminatedThis early-stage trial tested a new drug called AP026, a fusion protein that targets two pathways (GLP-1 and FGF21) to potentially treat type 2 diabetes. The study planned to enroll 74 healthy adults but was terminated early after only 14 participants. The main goal was to check …
Phase: PHASE1 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can cutting carbs and a diabetes drug help kidneys?
Disease control TerminatedThis small pilot study tested whether a low-carb diet (50-100 grams of carbs per day) combined with the diabetes drug dapagliflozin could improve blood sugar control in people with chronic kidney disease and prediabetes or type 2 diabetes. Four participants were split into two gr…
Phase: NA • Sponsor: Department of Nephrology Clinic Ottakring Vienna • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Plant-Based diet shows promise for diabetes remission in new study
Disease control TerminatedThis study looked at whether a plant-based diet and lifestyle changes could help people with type 2 diabetes, prediabetes, or obesity improve their health. Researchers aimed for diabetes remission (normal blood sugar without medication for at least 3 months) or significant weight…
Phase: NA • Sponsor: National Council of Scientific and Technical Research, Argentina • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can a common diabetes drug shield transplanted kidneys?
Disease control TerminatedThis study tested the drug empagliflozin (a diabetes medicine) in 20 people who had a kidney transplant, some with type 2 diabetes and some without. The goal was to see if the drug could help protect their heart and kidney function. The trial was stopped early, so the findings ar…
Phase: PHASE2 • Sponsor: Duke University • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Probiotic study for diabetes and COPD halted early
Disease control TerminatedThis study looked at whether taking probiotics alongside regular treatment could help lower blood sugar and improve lung function in people with both type 2 diabetes and chronic obstructive pulmonary disease (COPD). The trial planned to enroll 30 adults aged 50-85, but it was ter…
Phase: NA • Sponsor: Glac Biotech Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Experimental diabetes drug trial halted early – what happened?
Disease control TerminatedThis study tested a new drug called CK-0045 in 90 adults with type 2 diabetes and overweight or obesity. Participants received weekly injections of CK-0045 or a placebo for 16 weeks to see if it improved blood sugar after meals and reduced body weight. The trial was terminated ea…
Phase: PHASE2 • Sponsor: Cytoki Pharma • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Diabetes drug liraglutide may fight fatty liver, but trial halted early
Disease control TerminatedThis study looked at whether liraglutide, a diabetes drug, can reduce liver fat and improve cholesterol in people with type 2 diabetes. It involved 127 patients who took liraglutide for 6 months, with liver fat measured by MRI. However, the trial was terminated early, so the full…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Does longer glucose monitoring help diabetes control? small study halted early
Disease control TerminatedThis study aimed to see if using a professional continuous glucose monitor (CGM) for 6 months, instead of 3 months, helps people with poorly controlled type 2 diabetes (who don't use insulin) spend more time with healthy blood sugar levels. Only 12 participants were enrolled befo…
Phase: NA • Sponsor: East Tennessee State University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Digital diabetes coach put to the test – but trial ends early
Disease control TerminatedThis study tested a digital system called 'Live well with type 2 diabetes' to help people manage their condition. It compared the digital program to usual care for 138 adults recently diagnosed with type 2 diabetes. The main goal was to see if it improved blood sugar levels. Howe…
Phase: NA • Sponsor: Region Jönköping County • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Heart drug for diabetics shows promise but trial ends early
Disease control TerminatedThis study tested whether pemafibrate, a drug that lowers triglycerides, could reduce heart attacks, strokes, and heart-related deaths in over 10,000 people with type 2 diabetes and high triglycerides. Participants took either pemafibrate or a placebo twice daily. The trial was t…
Phase: PHASE3 • Sponsor: Kowa Research Institute, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Insulin showdown: toujeo vs tresiba for diabetics with kidney disease
Disease control TerminatedThis study compared two long-acting insulins, Toujeo and Tresiba, in people with type 2 diabetes who also have kidney problems and had never used insulin before. The goal was to see which one controls blood sugar better and causes fewer low blood sugar events. The trial was stopp…
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 14:43 UTC
-
Yoghurt study aimed to curb diabetes risk, but ended early
Prevention TerminatedThis study tested whether eating yoghurt daily for 24 weeks could improve blood sugar control in adults with prediabetes (high risk for type 2 diabetes). Only 8 people enrolled, and the study was stopped early, so no firm conclusions can be drawn. The goal was to see if a simple …
Phase: NA • Sponsor: Danone Global Research & Innovation Center • Aim: Prevention
Last updated Jun 27, 2026 08:10 UTC
-
Diabetes education tailored for hispanic men shows promise in small study
Symptom relief TerminatedThis study tested whether a five-week culturally tailored diabetes education program could help Hispanic men aged 18-64 with type 2 diabetes improve their self-management behaviors like healthy eating, physical activity, and medication use. The program was designed specifically f…
Phase: NA • Sponsor: Hackensack Meridian Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:36 UTC
-
Can a short daily workout help hospitalized diabetes patients?
Symptom relief TerminatedThis study tested whether hospitalized adults with type 2 diabetes or prediabetes could safely do 30 minutes of resistance training each day. The goal was to see if this exercise routine is feasible and if it helps control blood sugar and prevent muscle loss during a hospital sta…
Phase: PHASE1 • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Diabetes and antibiotics: a risky mix for the heart?
Knowledge-focused TerminatedThis study looks at how high blood sugar combined with a medication called moxifloxacin (an antibiotic known to affect heart rhythm) impacts the heart's electrical activity in people with insulin-resistant type 2 diabetes. Researchers will measure changes in heart tracings (ECGs)…
Phase: NA • Sponsor: Richmond Pharmacology Limited • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Tiny nerves may explain chronic cough in diabetes
Knowledge-focused TerminatedThis study looked at whether people with type 2 diabetes who have a chronic cough also have damage to small nerves in their skin. Researchers compared diabetic patients with and without chronic cough using nerve tests and skin biopsies. The study was terminated early with only 7 …
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Blood markers may forecast diabetes cure after gastric bypass
Knowledge-focused TerminatedThis study aimed to find blood and tissue markers that could predict whether obese patients with type 2 diabetes would go into remission after bariatric surgery. Researchers planned to measure 9 specific molecules in blood samples and also collect fat and muscle tissue during sur…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
When you eat matters: stanford study tests meal timing for better blood sugar and sleep
Knowledge-focused TerminatedThis Stanford study looked at how changing when and what you eat affects blood sugar, body temperature, and sleep in people with prediabetes, type 2 diabetes, and healthy adults. Participants followed different meal-timing schedules, like eating within a 10-hour window starting e…
Phase: NA • Sponsor: Stanford University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Diabetes Drug's heart benefits probed in tiny, terminated study
Knowledge-focused TerminatedThis study aimed to see how dapagliflozin, a diabetes drug, affects blood vessel health in people with type 2 diabetes. Researchers planned to measure blood pressure and other markers of vascular function. However, the trial was terminated early and only enrolled 4 participants, …
Phase: PHASE4 • Sponsor: Boston University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Can your personality change your diabetes genes?
Knowledge-focused TerminatedThis study looked at whether people with type 1 or type 2 diabetes who have a 'Type A' (impatient, proactive) or 'Type B' (calm, slow) personality show different genetic markers linked to inflammation and stress. Researchers planned to collect blood samples and have participants …
Phase: NA • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Diabetes drug may alter your taste buds and food desires
Knowledge-focused TerminatedThis study looked at how the diabetes medication Liraglutide (Victoza) affects taste, food cravings, and eating habits in people with type 2 diabetes who are overweight. Researchers compared three groups: patients starting Liraglutide, diabetic patients not on the drug, and healt…
Phase: PHASE4 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Early eating study for diabetes ends early
Knowledge-focused TerminatedThis study looked at whether eating most calories before 2 PM could help control blood sugar in people with type 2 diabetes. It planned to enroll 10 participants but was terminated after only 2 joined. The goal was to compare early eating with a typical eating pattern over six da…
Phase: NA • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
New urine test could reveal if diabetes patients are taking their pills
Knowledge-focused TerminatedThis study aimed to see if a new urine test can accurately tell whether people with type 2 diabetes are taking their medications as prescribed. Researchers planned to compare the urine test results with standard methods like questionnaires and pharmacy records in 90 participants.…
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
Study on arthritis and diabetes link halted early
Knowledge-focused TerminatedThis study looked at whether people with both rheumatoid arthritis and type 2 diabetes have a harder time controlling their diabetes than those with osteoarthritis and diabetes. Researchers planned to follow 176 adults to see how quickly they needed new diabetes treatments. Howev…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:07 UTC